tolbutamide has been researched along with E coli Infections in 1 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pickkers, P | 1 |
| Dorresteijn, MJ | 1 |
| Bouw, MP | 1 |
| van der Hoeven, JG | 1 |
| Smits, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Blockade of Vascular Potassium Channels During Human Endotoxemia[NCT00185003] | Phase 1 | 36 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for tolbutamide and E coli Infections
| Article | Year |
|---|---|
In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Topics: Adult; Dose-Response Relationship, Drug; Endotoxemia; Endotoxins; Enzyme Inhibitors; Escherichia col | 2006 |